Identifying preliminary domains to detect and measure rheumatoid arthritis flares: Report of the OMERACT 10 RA Flare Workshop

Journal of Rheumatology

Volumn 38, Issue 8, 2011, Pages 1751-1758

  Bingham III, Clifton O ^a,e   Alten, Rieke ^b,e   Bartlett, Susan J ^c,e   Bykerk, Vivian P ^d,e   Brooks, Peter M ^e,f   Choy, Ernest ^e,f   Christensen, Robin ^e,g   Furst, Daniel E ^e,h   Hewlett, Sarah E ^e,i   Leong, Amye ^e,j   May, James E ^e,k   Montie, Pam ^e,k   Pohl, Christof ^b,e   Sanderson, Tessa C ^e,i   Strand, Vibeke ^e,l   Woodworth, Thasia G ^e,m  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c MCGILL UNIVERSITY   (Canada)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e UNIVERSITY OF QUEENSLAND   (Australia)

^f KING'S COLLEGE LONDON   (United Kingdom)

^g Mental Health Services CPH   (Denmark)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ UNIVERSITY OF THE WEST OF ENGLAND   (United Kingdom)

^j HEALTHY MOTIVATION   (United States)

^k ARTHRITIS RESEARCH CENTRE OF CANADA   (Canada)

^l STANFORD UNIVERSITY   (United States)

^m Leading Edge Clinical Research LLC   (United States)

more..

Author keywords

Disease activity; Outcome assessment; Rheumatoid arthritis

Indexed keywords

CLINICAL ASSESSMENT TOOL; CONFERENCE PAPER; CONSENSUS; CONTROLLED STUDY; DELPHI STUDY; DISEASE ACTIVITY; DISEASE EXACERBATION; DISEASE SEVERITY; DOCTOR PATIENT RELATION; FATIGUE; HEALTH CARE ORGANIZATION; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RESEARCH; OUTCOME ASSESSMENT; OUTCOME MEASURES IN RHEUMATOLOGY CLINICAL TRIALS; PATIENT ASSESSMENT; PATIENT ATTITUDE; PATIENT CARE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RIGIDITY; WORKSHOP;

ARTHRITIS, RHEUMATOID; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RHEUMATOLOGY; TREATMENT OUTCOME;

EID: 79961108254     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.110401     Document Type: Conference Paper

References (16)

1. Sanderson T, Morris M, Calnan M, Richards P, Hewlett S. Patient perspective of measuring treatment efficacy: the rheumatoid arthritis patient priorities for pharmacologic interventions outcomes. Arthritis Care Res 2010;62:647-56.
2. Bingham CO 3rd, Pohl C, Woodworth TG, Hewlett SE, May JE, Rahman MU, et al. Developing a standardized definition for disease "flare" in rheumatoid arthritis (OMERACT 9 Special Interest Group). J Rheumatol 2009;36:2335-41.
3. van Vollenhoven RF, Boumpas D, Westhovens R, Brzosko M, Svensson K, Bjorneboe O, et al. Response, remission, and flare during early treatment of rheumatoid arthritis with infliximab: The REMARK Study [abstract]. Ann Rheum Dis 2010;69 Suppl3:535.
4. Den Broeder AA, Creemers MC, van Gestel AM, van Riel PL. Dose titration using the Disease Activity Score (DAS28) in rheumatoid arthritis patients treated with anti-TNF-alpha. Rheumatology 2002;41:638-42. (Pubitemid 34618881)
5. van den Bemt BJ, den Broeder AA, Snijders GF, Hekster YA, van Riel PL, Benraad B, et al. Sustained effect after lowering high-dose infliximab in patients with rheumatoid arthritis: a prospective dose titration study. Ann Rheum Dis 2008;67:1697-701.
6. Strand V, Crawford B. Improvement in health-related quality of life in patients with systemic lupus erythematosus following sustained reductions in anti-dsDNA antibodies. Expert Rev Pharmacoeconomics Outcomes Res 2005;5:317-26. (Pubitemid 40894969)
7. Bingham CO, Pohl C, Alten R, Christensen C, Choy EH, Hewlett SE, et al. "Flare" and disease worsening in rheumatoid arthritis: time for a definition. Int J Adv Rheumatol 2009;7:85-91.
8. Alten R, Pohl C, Choy EH, Christensen R, Furst DE, Hewlett S, et al. Developing a construct to evaluate flares in rheumatoid arthritis: a conceptual report of the OMERACT RA Flare Definition Working Group. J Rheumatol 2011;38:1745-50.
9. Woodworth T, Furst DE, Alten R, Bingham CO, Yocum D, Sloan V, et al. Standardizing assessment and reporting of adverse effects in rheumatology clinical trials II: the Rheumatology Common Toxicity Criteria v.2.0. J Rheumatol 2007;34:1401-14. (Pubitemid 46898128)
10. Hewlett S, Sanderson T, May J, Alten R, Bingham CO, Cross M, et al. "I feel like a tractor has run over me": Rheumatoid arthritis flare is more than a high joint count - an international patient perspective on flare where medical help is sought. Rheumatology 2011; [in press].
11. Hewlett S, Sanderson T, May J, Bingham CO, March L, Alten R, et al. "Just shoot me": RA patients experience flare as more than painful, swollen joints [abstract]. Rheumatology 2010;49 Suppl 1;141:285.
12. Hewlett S, Sanderson T, May J, Bingham CO, March L, Alten R, et al. Patients' words for scales to measure flare: "Sometimes it doesn't fit into that neat little box" [abstract]. Rheumatology 2010;49 Suppl 1;143:289.
13. Bykerk V. RA flares are common - BRASS [abstract]. Arthritis Rheum 2010;62 Suppl.
14. Vander Cruyssen B, Van Looy S, Wyns B, Westhovens R, Durez P, Van den Bosch F, et al. DAS28 best reflects the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in patients under infliximab treatment. Arthritis Res Ther 2005;7:R1063-71.
15. Kirwan JR, Minnock P, Adebajo A, Bresnihan B, Choy E, de Wit M, et al. Patient perspective: fatigue as a recommended patient centered outcome measure in rheumatoid arthritis. J Rheumatol 2007;34:1174-7. (Pubitemid 46774870)
16. Gossec L, Dougados M, Rincheval N, Balanescu A, Boumpas DT, Canadelo S, et al. Elaboration of the preliminary Rheumatoid Arthritis Impact of Disease (RAID) score: a EULAR initiative. Ann Rheum Dis 2009;68:1680-5.